446 related articles for article (PubMed ID: 21684027)
1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.
Blanchard P; Baujat B; Holostenco V; Bourredjem A; Baey C; Bourhis J; Pignon JP;
Radiother Oncol; 2011 Jul; 100(1):33-40. PubMed ID: 21684027
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
Pignon JP; Bourhis J; Domenge C; Designé L
Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.
Pignon JP; le Maître A; Maillard E; Bourhis J;
Radiother Oncol; 2009 Jul; 92(1):4-14. PubMed ID: 19446902
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Lacas B; Carmel A; Landais C; Wong SJ; Licitra L; Tobias JS; Burtness B; Ghi MG; Cohen EEW; Grau C; Wolf G; Hitt R; Corvò R; Budach V; Kumar S; Laskar SG; Mazeron JJ; Zhong LP; Dobrowsky W; Ghadjar P; Fallai C; Zakotnik B; Sharma A; Bensadoun RJ; Ruo Redda MG; Racadot S; Fountzilas G; Brizel D; Rovea P; Argiris A; Nagy ZT; Lee JW; Fortpied C; Harris J; Bourhis J; Aupérin A; Blanchard P; Pignon JP;
Radiother Oncol; 2021 Mar; 156():281-293. PubMed ID: 33515668
[TBL] [Abstract][Full Text] [Related]
5. Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
Dauzier E; Lacas B; Blanchard P; Le QT; Simon C; Wolf G; Janot F; Horiuchi M; Tobias JS; Moon J; Simes J; Deshmane V; Mazeron JJ; Mehta S; Zaktonik B; Tamura M; Moyal E; Licitra L; Fortpied C; Haffty BG; Ghi MG; Gregoire V; Harris J; Bourhis J; Aupérin A; Pignon JP;
Oral Oncol; 2019 Aug; 95():106-114. PubMed ID: 31345376
[TBL] [Abstract][Full Text] [Related]
6. The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: A systematic review and meta-analysis.
Nie D; Wang X; Sun M; Feng Z; Pei F; Liu W; Wang Z; Han F
Radiother Oncol; 2021 May; 158():13-20. PubMed ID: 33587969
[TBL] [Abstract][Full Text] [Related]
7. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
8. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.
Ma J; Liu Y; Huang XL; Zhang ZY; Myers JN; Neskey DM; Zhong LP
Oral Oncol; 2012 Nov; 48(11):1076-84. PubMed ID: 22800881
[TBL] [Abstract][Full Text] [Related]
13. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
[TBL] [Abstract][Full Text] [Related]
14. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
15. nab-Paclitaxel-based induction chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinoma.
Adkins D; Ley J; Oppelt P; Wildes TM; Gay HA; Daly M; Rich J; Paniello RC; Jackson R; Pipkorn P; Nussenbaum B; Trinkaus K; Thorstad W
Oral Oncol; 2017 Sep; 72():26-31. PubMed ID: 28797458
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
17. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
18. Predictive classifier for intensive treatment of head and neck cancer.
Zakeri K; Rotolo F; Lacas B; Vitzthum LK; Le QT; Gregoire V; Overgaard J; Hackshaw A; Zackrisson B; Parmar MKB; Burtness BA; Ghi MG; Sanguineti G; O'Sullivan B; Fortpied C; Bourhis J; Shen H; Harris J; Michiels S; Pignon JP; Mell LK;
Cancer; 2020 Dec; 126(24):5263-5273. PubMed ID: 33017867
[TBL] [Abstract][Full Text] [Related]
19. [Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?].
Pignon JP; Baujat B; Bourhis J
Cancer Radiother; 2005 Feb; 9(1):31-6. PubMed ID: 15804617
[TBL] [Abstract][Full Text] [Related]
20. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
